Request a Rep
Request a visit from an Ascendis representative.
Please fill out the form below.
*Required field.
Request a visit from an Ascendis representative.
Please fill out the form below.
*Required field.
IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS
SKYTROFA is contraindicated in patients with:
Click here to contact Ascendis Pharma Medical Information or call 1-844-442-7236.
INDICATION
SKYTROFA® is a human growth hormone (GH) indicated for the treatment of pediatric patients aged ≥ 1 years weighing ≥ 11.5 kg with growth failure due to inadequate secretion of endogenous GH.
IMPORTANT SAFETY
INFORMATION
CONTRAINDICATIONS
SKYTROFA is contraindicated in patients with:
WARNINGS AND PRECAUTIONS
ADVERSE REACTIONS
The most common adverse reactions (≥ 5%) in patients treated with SKYTROFA were: viral infection (15%), pyrexia (15%), cough (11%), nausea and vomiting (11%), hemorrhage (7%), diarrhea (6%), abdominal pain (6%), and arthralgia and arthritis (6%).
DRUG INTERACTIONS
You are encouraged to report side effects to FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Ascendis Pharma at 1-844-442-7236.
Please click here for full Prescribing Information for SKYTROFA.